Iodine is an essential element for thyroid hormone synthesis. The thyroid g
land has the capacity and holds the machinery to handle the iodine efficien
tly when the availability of iodine becomes scarce, as well as when iodine
is available in excessive quantities. The latter situation is handled by th
e thyroid by acutely inhibiting the organification of iodine, the so-called
acute Wolff-Chaikoff effect, by a mechanism not well understood 52 years a
fter the original description. It is proposed that iodopeptide(s) are forme
d that temporarily inhibit thyroid peroxidase (TPO) mRNA and protein synthe
sis and, therefore, thyroglobulin iodinations. The Wolff-Chaikoff ef feet i
s an effective means of rejecting the large quantities of iodide and theref
ore preventing the thyroid from synthesizing large quantities of thyroid ho
rmones. The acute Wolff-Chaikoff effect lasts for few a days and then, thro
ugh the so-called "escape" phenomenon, the organification of intrathyroidal
iodide resumes and the normal synthesis of thyroxine (T-4) and triiodothyr
onine (T-3) returns. This is achieved by decreasing the intrathyroidal inor
ganic iodine concentration by down regulation of the sodium iodine symporte
r (NIS) and therefore permits the TPO-H2O2 system to resume normal activity
. However, in a few apparently normal individuals, in newborns and fetuses,
in some patients with chronic systemic diseases, euthyroid patients with a
utoimmune thyroiditis, and Graves' disease patients previously treated with
radioimmunoassay (RAI), surgery or antithyroid drugs, the escape from the
inhibitory effect of large doses of iodides is not achieved and clinical or
subclinical hypothyroidism ensues. Iodide-induced hypothyroidism has also
been observed in patients with a history of postpartum thyroiditis, in euth
yroid patients after a previous episode of subacute thyroiditis, and in pat
ients treated with recombinant interferon-alpha who developed transient thy
roid dysfunction during interferon-alpha treatment. The hypothyroidism is t
ransient and thyroid function returns to normal in 2 to 3 weeks after iodid
e withdrawal, but transient T-4 replacement therapy may be required in some
patients. The patients who develop transient iodine-induced hypothyroidism
must be followed long term thereafter because many will develop permanent
primary hypothyroidism.